Imagine if you will, a future in which a cancer diagnosis will be treated with a lifestyle change, like a chronic condition. Survivable. Manageable. Like Diabetes. Sure, to receive a cancer diagnosis today does not mean what it meant twenty years ago, but we are also unlikely to reach a point of ever acting casual about the term or the treatment plan. In the meantime though, the increasing prevalence of personal data collection is driving new approaches in care plans that have a real shot at improving quality of life.

The narrative of one’s life can be seen in the data – everything from where you live, what you eat, how you workout, even what you search for on the internet. The sources of such personal data come from places like clinical trials, biosensors, and wearables and is being stored in your Electronic Medical Record (hopefully). The sticking point though is the advancement of technological tools to view, aggregate, extract, and analyze relevant data to derive a meaningful plan of attack (er, treatment plan). One interoperable tool that plugs right into the EMR is Cota Healthcare. Pair this with omics data and genome sequencing technology, like 2bPrecise, and physicians are gaining insight into what makes you, you. And thus are better able to customize a bespoke cancer treatment plan, designed for you and only you. Targeted therapy works to molecularly target the rapidly dividing cancer cells, and more-or-less leave the healthy cells to continue being healthy, wrecking less havoc on a patient’s body and is far less toxic than tradition chemotherapy.

Looking forward, the advent of blockchain technology is hopeful to further intercept the round robin of interoperability and solidify a chronological timeline of personalized data that will further clarify the patient narrative leading to even more precise treatment plans. The path we’re staring down right now is a new convergence of scientific advances and technological support that translates into personalized care. The ultimate goal of which is to administer the right treatment, to the right person, at the right time – as is the definition of Precision Medicine. 

Learn more about how omics data is driving new care plans at the Technology for Precision Health Summit next week 12/10 in San Francisco, and tune in on Thursday 12/7 for a Part Two in which we discuss how new tools and research are used to predict and prevent cancer.

Register here for next week’s summit!